SCHEMBL9646948

SCHEMBL9646948

Cc1ccc(Cc2c[nH]cn2)c(O)c1C(N)=O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PKMYT1 Q99640 6/20 0.32
▸ WEE1 P30291 2/20 0.31
▸ MYT1 Q01538 2/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ CREBBP Q92793 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10401596 0.99 PKMYT1 (0.31) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL9647525 0.88 P2RX3 (0.34) —
SCHEMBL9647120 0.86 PRKCI (0.34) —
Hydrochloric Acid SCHEMBL10402300 0.85 PRKCI (0.33) —
SCHEMBL10402416 0.84 MAPT (0.39) —
SCHEMBL9648217 0.82 PKMYT1 (0.34) PKMYT1WEE1MYT1CDK1CREBBP
Hydrochloric Acid SCHEMBL10401606 0.81 PKMYT1 (0.33) PKMYT1WEE1MYT1CDK1CREBBP
SCHEMBL9646843 0.77 PRKCI (0.35) —
SCHEMBL9645373 0.76 NNMT (0.32) PKMYT1
Mivazerol SCHEMBL8097939 0.76 PARP1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0341231-B1 SUBSTITUTED 1-(1H-IMIDAZOL-4-YL)ALKYL BENZAMIDES U C B, S.A. (BE) 1992-11-19 — — EP claimed
US-4923865-A Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and as alpha-2-adrenergic receptor agonists U C B SOCIETE ANONYME (BE) 1990-05-08 — — US claimed
EP-0341231-A1 Substituted 1-(1H-imidazol-4-yl)alkyl benzamides U C B, S.A. (BE) 1989-11-08 — — EP claimed
EP-0341231-B1 SUBSTITUTED 1-(1H-IMIDAZOL-4-YL)ALKYL BENZAMIDES U C B, S.A. (BE) 1992-11-19 — — EP disclosed
US-4923865-A Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and as alpha-2-adrenergic receptor agonists U C B SOCIETE ANONYME (BE) 1990-05-08 — — US disclosed
EP-0341231-A1 Substituted 1-(1H-imidazol-4-yl)alkyl benzamides U C B, S.A. (BE) 1989-11-08 — — EP disclosed
Send feedback